Stock Redeemed for Midwest Nursing Home Shareholders
Kegler Brown represented the shareholders of a health care company that owns and operates nursing homes, rehabilitation communities and assisted living facilities throughout Ohio and Pennsylvania, in connection with a strategic redemption transaction. Financial terms of the December 2012 transaction were not disclosed
Early-Stage Medical Technology Acquisition
Kegler Brown represented a publicly traded global medical technology company in its acquisition of an early-stage medical technology business in July 2012.
Acquisition of Assets and IP of Software-as-a-Service Provider
The team at Kegler Brown represented a leading global provider of clinical, commercial and consulting services to pharmaceutical, biotech and life sciences companies in its acquisition of the assets and intellectual property of a provider of software-as-a-service to companies deploying mobile web applications. The transaction was completed in June 2011.
Corporate Divestiture of Health Care Business Unit
In March 2011, Kegler Brown represented a publicly traded, global medical technology company in its sale of an instrument management and repair business to a private equity fund. Financial terms of the agreement were not disclosed.
Asset Sale of Two Ohio Medical Practices
Kegler Brown counseled a majority shareholder in the asset sale of two Columbus, Ohio, Neurological Sleep Centers and medical practices. The transaction was completed in February 2011. Financial terms of the deal were not disclosed.
Stock Purchase of Managed Care Organization
The lawyers at Kegler Brown represented a national claims and risk management service provider in its acquisition of an Ohio-based managed care organization. The transaction was completed in January 2011 and financial terms were not disclosed.
Divestiture of Medical Products Business Unit for Public Company
The transactional practice at Kegler Brown represented a publicly traded, global medical technology company its corporate divestiture of one of its business units to a strategic buyer. Financial terms of the November 2010 transaction were not disclosed.
Public Company Acquisition of Health Care Logistics Business
Kegler Brown represented a publicly traded, global health care company in connection with its acquisition of a shipping and freight management services business that services the health care industry. Financial terms of the 2010 transaction were not disclosed.
$225 Million Stock Purchase in Health Care Industry
The attorneys at Kegler Brown advised a publicly traded, global medical technology company in connection with its May 2010 stock purchase bid for a leading innovator in clinically differentiated needleless access connectors and administration sets that deliver intravenous medication to patients.
Acquisition of Nuclear Pharmacy Business
Our M+A lawyers represented a publicly-traded, global healthcare company in its acquisition of a nuclear pharmacy business with multiple locations and cyclotrons throughout the Southwest.
Divestiture of Medical Product Business Unit to East Coast Private Equity Firm
In September 2008, the Kegler Brown M+A team represented a publicly-traded global healthcare company in the sale of its orthopedic product manufacturing business unit an east coast private equity firm.
Sale of Health Care Business Unit to Chicago PE Firm
Lawyers at Kegler Brown represented a publicly-traded global healthcare company in its sale of several of its business units focused on the enteral feeding, vascular access, catheter location device and surgical protection systems markets. The corporate divestitures closed in August 2008.